Mycobacterium Tuberculosis; drug susceptibility test; multidrug resistant tuberculosis;
结核分枝杆菌；药敏试验； 耐多药结核；
Objective To investigate the emerged causes and treatment methods of primarily multidrug resistant tuberculosis.
目的探讨初始多耐药结核的发病原因及治疗对策。
Multidrug resistant tuberculosis, or MDR-TB, will not get better with antibiotics normally used for tuberculosis.
使用常用于治疗肺结核的抗生素将不会使耐多药物性结核m DR -tb病转好。
Enterococci are known as the most important multidrug resistant opportunistic pathogens and common cause of hospital-acquired infections.
肠球菌是多重耐药的重要条件致病菌和医院感染常见病原菌。
Occurrence of multidrug resistant strains closely associated with abuse of antibiotics narrowed the clinical option of common antibiotics.
抗生素的滥用导致多重耐药菌株的出现，限制了临床常规抗生素的使用范围。
MDR-TB (Multidrug Resistant TB) describes strains of tuberculosis that are resistant to at least the two main first-line TB drugs - isoniazid and rifampicin.
耐多药结核描述至少对两种主要一线抗结核药物-异烟肼和利福平具耐药性的结核菌株。
With the sharp rise of antimicrobial resistance in the world, it is key that research now focuses on antimicrobial resistance and the spread of multidrug resistant pathogens.
随着世界抗菌素耐药性的激增，现在必须着重研究抗菌素耐药性以及多药物耐药性病原体的传播问题。
Objective To investigate the reversing effect of doxorubicin-loaded polyisobultylcyanoacrylate nanoparticles (NP-DOX) on multidrug resistant cell line K562/DOX and the possible mechanism.
目的合成阿霉素聚氰基丙烯酸异丁酯纳米粒，观察其对阿霉素耐受性细胞株K5 6 2 （K5 6 2 /DOX）耐药性逆转效果并探讨可能机制。
The Philippines has tried to control multidrug-resistant TB (MDR -TB ) for nearly as long as any country in the world.
菲律宾像世界任何国家一样，长期以来设法控制耐多药结核病。
Lapses in control drive the rise of multidrug-resistant TB, which is far more costly and difficult to treat, and remind us of the constant risk of setbacks.
控制失效导致耐多药结核病病例上升，而此类结核病的治疗要困难许多，也昂贵许多。这提醒我们要时刻牢记挫折风险。
The numbers of HIV-positive and multidrug-resistant TB (MDR-TB) patients diagnosed and treated in 2005, although increasing, were far lower than proposed in the Global Plan for 2006.
2005年诊断和治疗的艾滋病毒阳性和耐多药结核患者的人数虽然在增加，但是远低于2006年全球计划中提出的人数。
During this period, they can spread the multidrug-resistant disease to others.
在这段时间内，患者有可能把耐多药疾病传给他人。
But now, says the Lancet paper, clinical microbiologists increasingly agree that multidrug-resistant Gram-negative bacteria, which thrive in the gut, pose the greatest risk to public health.
但是该论文指出，现在临床微生物学家日益赞同，活跃于肠道中的多耐药性革兰阴性菌，才对公众健康构成最大威胁。
The threat of returning to a pre-antibiotic era is genuine and probably most vividly illustrated by the rise of multidrug-resistant and extensively drug-resistant tuberculosis.
回到前抗生素时代的威胁是真实的，而耐多药和广泛耐药结核病的增多则是最生动的实例。
It is time for countries with rapidly growing economies and a heavy burden of multidrug-resistant tuberculosis to step up their commitment and financing.
对那些经济增长很快并且面临耐多药结核病沉重负担的国家而言，现在到了加强承诺并提供资助的时候了。
For example, 28% of all people newly diagnosed with TB in one region of north western Russia had the multidrug-resistant form of the disease (MDR-TB) in 2008.
比如在俄罗斯西北部的一个地区，2008年新诊断为结核病的病人当中有28%属耐多药结核病人。
A particularly dangerous form of TB is multidrug-resistant TB (MDR-TB), which is TB that resists at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
特别危险的结核病是多抗药性结核病(multidrug - resistantTB)。这是抗拒至少两种最有效的抗肺结核药——异烟肼和利福平的结核病。
Prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
预防和控制耐多药结核病和广泛耐药结核病。
The risk of leaving multidrug-resistant tuberculosis untreated.
若不治疗耐多药结核病的危险。
About 440 000 new cases of multidrug-resistant tuberculosis (MDR-TB) emerge annually, causing at least 150 000 deaths.
每年出现约44万耐多药结核病(MDR - TB)新发病例，至少造成15万例死亡。
In her Ministry office recently, John Donnelly interviewed her about a threat that gives her great concern - the spread of multidrug-resistant TB (MDR-TB).
不久前johnDonnelly在她的办公室里采访了她，内容涉及耐多药结核病蔓延问题，这一威胁令她十分担心。
However, there could be worse to come. Nearly 450, 000 new cases of multidrug-resistant tuberculosis are recorded each year; one-third of these people die from the disease.
然而情况可能更加严重，全世界每年新增约45万例多重抗药性肺结核感染的新病例，其中三分之一死于该病。
There were an estimated 0.5 million cases of multidrug-resistant TB (MDR-TB) in 2006.
在2006年，估计有50万例耐多药结核病例。
There were an estimated 0.5 million cases of multidrug-resistant TB (MDR-TB) in 2006.
在2006年，估计有50万例耐多药结核病例。
应用推荐